当前位置: X-MOL 学术Microb. Pathog. › 论文详情
Use of Nasoill® via intranasal to control the harmful effects of Covid-19.
Microbial Pathogenesis ( IF 2.914 ) Pub Date : 2020-09-17 , DOI: 10.1016/j.micpath.2020.104504
Carlos Eduardo Cuevas-Barragan,Marco Tulio Buenrostro-Nava,Gabriela Monserrat Palos-Gómez,Elisa Alejandra Ramirez-Padilla,Blanca Isabel Mendoza-Macias,Raymundo Rene Rivas-Caceres

In the absence of vaccines and antiviral drugs available to prevent and treat COVID-19, it becomes imperative to find or use all those products with the potential to fight this virus. This article is an attempt to propose ways to prevent, treat and control the COVID-19 virus, using a product based on plant extracts with the potential to reduce the symptoms caused by the SARS-CoV-2 virus. Nasoil® counts as one of its main components, Asclepias curassavica extracts, and in the present study it has been shown that it is an effective adjuvant in the treatment of Covid-19, increasing the respiratory capacity of the patients (SpO2> 90%) and reducing the symptoms from the first application, improving the patients around the fifth to the eighth application. At a preventive level, the individuals in this study who have applied it (400 individuals) only a 3.15% of these presented symptoms, disappearing when increasing the weekly applications.



中文翻译:

通过鼻内使用Nasoill®来控制Covid-19的有害作用。

在没有可用于预防和治疗COVID-19的疫苗和抗病毒药物的情况下,必须寻找或使用所有具有抗击这种病毒潜能的产品。本文试图提出一种使用植物提取物的产品来预防,治疗和控制COVID-19病毒的方法,该产品具有减轻SARS-CoV-2病毒引起的症状的潜力。Nasoil®算作其主要成分之一,即Asclepias curassavica提取物,并且在本研究中表明,它是治疗Covid-19的有效佐剂,可增强患者的呼吸能力(SpO2> 90%),并从首次应用起减轻症状,从而改善患者大约第五至第八个应用程序。在预防水平上,使用本研究的个体(400个体)中只有3.15%出现症状,当增加每周使用量时消失。

更新日期:2020-09-24
全部期刊列表>>
专攻离子通道生理学研究
2021中国学者有奖调研
JACS
中国作者高影响力研究精选
虚拟特刊
屿渡论文,编辑服务
浙大
上海中医药大学
南方科技大学
舒伟
季恒星
毛凌玲
灵长脑研究中心
上海交大
清华杨杰
中科院
南开大学
隐藏1h前已浏览文章
课题组网站
新版X-MOL期刊搜索和高级搜索功能介绍
ACS材料视界
华辉
天合科研
x-mol收录
试剂库存
down
wechat
bug